BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25927440)

  • 1. Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.
    Naipal KA; Raams A; Bruens ST; Brandsma I; Verkaik NS; Jaspers NG; Hoeijmakers JH; van Leenders GJ; Pothof J; Kanaar R; Boormans J; van Gent DC
    PLoS One; 2015; 10(4):e0126029. PubMed ID: 25927440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo destabilization and functional defects of the xeroderma pigmentosum C protein caused by a pathogenic missense mutation.
    Yasuda G; Nishi R; Watanabe E; Mori T; Iwai S; Orioli D; Stefanini M; Hanaoka F; Sugasawa K
    Mol Cell Biol; 2007 Oct; 27(19):6606-14. PubMed ID: 17682058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair.
    Sugasawa K; Ng JM; Masutani C; Iwai S; van der Spek PJ; Eker AP; Hanaoka F; Bootsma D; Hoeijmakers JH
    Mol Cell; 1998 Aug; 2(2):223-32. PubMed ID: 9734359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression.
    Chen Z; Yang J; Wang G; Song B; Li J; Xu Z
    Cancer Res; 2007 May; 67(10):4578-85. PubMed ID: 17510383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated NER expressions of XPF and XPC associated with smoking are involved in the recurrence of bladder cancer.
    Qiu J; Wang X; Meng X; Zheng Y; Li G; Ma J; Ye G; Li Y; Li J
    PLoS One; 2014; 9(12):e115224. PubMed ID: 25535740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPC deficiency is related to APE1 and OGG1 expression and function.
    de Melo JT; de Souza Timoteo AR; Lajus TB; Brandão JA; de Souza-Pinto NC; Menck CF; Campalans A; Radicella JP; Vessoni AT; Muotri AR; Agnez-Lima LF
    Mutat Res; 2016; 784-785():25-33. PubMed ID: 26811994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein.
    Nishi R; Okuda Y; Watanabe E; Mori T; Iwai S; Masutani C; Sugasawa K; Hanaoka F
    Mol Cell Biol; 2005 Jul; 25(13):5664-74. PubMed ID: 15964821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPC beyond nucleotide excision repair and skin cancers.
    Zebian A; Shaito A; Mazurier F; Rezvani HR; Zibara K
    Mutat Res Rev Mutat Res; 2019; 782():108286. PubMed ID: 31843141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPC deficiency leads to centrosome amplification by inhibiting BRCA1 expression upon cisplatin-mediated DNA damage in human bladder cancer.
    Wang H; Huang Y; Shi J; Zhi Y; Yuan F; Yu J; Chen Z; Yang J
    Cancer Lett; 2019 Mar; 444():136-146. PubMed ID: 30579971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of arsenic on nucleotide excision repair: XPC function, protein level, and gene expression.
    Nollen M; Ebert F; Moser J; Mullenders LH; Hartwig A; Schwerdtle T
    Mol Nutr Food Res; 2009 May; 53(5):572-82. PubMed ID: 19382146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
    Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress.
    Melis JP; Kuiper RV; Zwart E; Robinson J; Pennings JL; van Oostrom CT; Luijten M; van Steeg H
    DNA Repair (Amst); 2013 Dec; 12(12):1081-6. PubMed ID: 24084170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPC is essential for nucleotide excision repair of zidovudine-induced DNA damage in human hepatoma cells.
    Wu Q; Beland FA; Chang CW; Fang JL
    Toxicol Appl Pharmacol; 2011 Mar; 251(2):155-62. PubMed ID: 21192964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of four novel XPC mutations in two xeroderma pigmentosum complementation group C patients and functional study of XPC Q320X mutant.
    Gu Y; Chang X; Dai S; Song Q; Zhao H; Lei P
    Gene; 2017 Sep; 628():162-169. PubMed ID: 28669926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.
    Khan SG; Yamanegi K; Zheng ZM; Boyle J; Imoto K; Oh KS; Baker CC; Gozukara E; Metin A; Kraemer KH
    Hum Mutat; 2010 Feb; 31(2):167-75. PubMed ID: 19953607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The UV-damaged DNA binding protein mediates efficient targeting of the nucleotide excision repair complex to UV-induced photo lesions.
    Moser J; Volker M; Kool H; Alekseev S; Vrieling H; Yasui A; van Zeeland AA; Mullenders LH
    DNA Repair (Amst); 2005 May; 4(5):571-82. PubMed ID: 15811629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of XPC: implications in cancer and oxidative DNA damage.
    Melis JP; Luijten M; Mullenders LH; van Steeg H
    Mutat Res; 2011; 728(3):107-17. PubMed ID: 21763452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
    Barckhausen C; Roos WP; Naumann SC; Kaina B
    Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.